Moraxella catarrhalis 拉丁名
ATCC BAA-1424 統(tǒng)一編號(hào)
Strain Designations 別名 59632
Isolation 分離基物 Sputum
St. John New Brunswick, Canada
isolation date: April 1, 2005
Biosafety Level 生物安全等級(jí) 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format 提供形式 freeze-dried
Preceptrol? no
Type Strain 模式菌種 no
Antibiotic Resistance
Macrolide susceptible
Susceptible to azithromycin, cefotaxime, cefuroxime, ciprofloxacin, levofloxacin, and trimethoprim-sulfamethoxazole
Comments 注釋 This strain is part of the national surveillance study called CROSS (Canadian Respiratory Organism Susceptibility Study).
Medium ATCC? Medium 44: Brain Heart Infusion Agar/Broth
Growth Conditions 生長(zhǎng)條件
Temperature 培養(yǎng)基: 37.0°C
Name of Depositor 寄存者 DJ Hoban
Special Collection ATCC
Isolation 分離基物 Sputum
St. John New Brunswick, Canada
isolation date: April 1, 2005
Year of Origin 收藏年份 2005
References 分離基物 Zhanel GG, et al. Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002. Antimicrob. Agents Chemother. 47(6):1875-1881, 2003. PubMed: 12760861
